Literature DB >> 4111197

Cellular immunity and hepatitis-associated, Australia antigen liver disease.

F J Dudley, R A Fox, S Sherlock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4111197     DOI： 10.1016/s0140-6736(72)90234-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  129 in total

1.  Hepatitis B surface antigen (HBsAg) infection in a hemodialysis unit. II. Factors affecting host immune response to HBsAg.

Authors:  D P Sengar; A Rashid; W A McLeish; J E Harris; R A Couture; M Sutherland
Journal:  Can Med Assoc J       Date:  1975-11-22       Impact factor: 8.262

Review 2.  Immunological reactivity and viral hepatitis.

Authors:  S Sherlock
Journal:  Bull N Y Acad Med       Date:  1975-04

3.  Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis.

Authors:  W M Lee; W D Reed; C G Mitchell; R M Galbraith; A L Eddleston; A J Zuckerman; R Williams
Journal:  Br Med J       Date:  1975-03-29

4.  Immunohistochemical patterns of hepatitis B surface antigen (HBsAg) in patients with hepatitis, renal homografts recipients and normal carriers.

Authors:  J P Camilleri; C Amat; M Chousterman; J P Petite; A Duboust; A Boddaert; A Paraf
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-12-08

5.  Hepatitis B virus suppresses expression of human beta-interferon.

Authors:  J S Twu; C H Lee; P M Lin; R H Schloemer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  Attempted treatment of fulminant viral hepatitis with human fibroblast interferon.

Authors:  F Milazzo; M Galli; P G Fassio; A Cargnel; A Pugliese; P A Tovo; G M Vigevani; R Esposito; A Lazzarin; F Caredda
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

7.  Immune response to hepatitis B surface antigen.

Authors:  A B Ibrahim; G N Vyas; H A Perkins
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

8.  T-lymphocytes and hepatitis B serology.

Authors:  E Kaklamani; D Trichopoulos; G Papaevangelou; M Drouga; D Karalis; G Papoutsakis
Journal:  Infection       Date:  1978       Impact factor: 3.553

9.  Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases.

Authors:  H Verhaegen; J De Cree; W De Cock; F Verbruggen
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

10.  Two distinct types of hepatitis in experimental hepatitis B virus infection.

Authors:  T Shikata; T Karasawa; K Abe
Journal:  Am J Pathol       Date:  1980-05       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.